Fulcrum Capital LLC Vertex Pharmaceuticals Inc Transaction History

Fulcrum Capital LLC

$456 Million
Q2 2025

A detailed history of Fulcrum Capital LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fulcrum Capital LLC holds 15,798 shares of VRTX stock, worth $6.13 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares

15,798

Previous 15,578 1.41%

Holding current value

$6.13 Million

Previous $7.55 Million 6.87%

% of portfolio

1.54%

Previous 1.73%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$421.16 - $509.5 $92,655 - $112,090	220 Added 1.41%	15,798 $7.03 Million
Q1 2025 Apr 08, 2025	BUY	$402.49 - $513.76 $33,809 - $43,155	84 Added 0.54%	15,578 $7.55 Million
Q4 2024 Jan 13, 2025	BUY	$396.64 - $516.74 $42,837 - $55,807	108 Added 0.7%	15,494 $6.24 Million
Q3 2024 Oct 22, 2024	SELL	$460.0 - $505.78 $4,600 - $5,057	-10 Reduced 0.06%	15,386 $7.16 Million
Q2 2024 Jul 22, 2024	BUY	$392.81 - $485.53 $79,347 - $98,077	202 Added 1.33%	15,396 $7.22 Million
Q1 2024 Apr 17, 2024	BUY	$407.69 - $446.08 $50,145 - $54,867	123 Added 0.82%	15,194 $6.35 Million
Q4 2023 Jan 10, 2024	SELL	$343.0 - $410.68 $281,260 - $336,757	-820 Reduced 5.16%	15,071 $6.13 Million
Q3 2023 Oct 13, 2023	SELL	$338.18 - $362.46 $20,290 - $21,747	-60 Reduced 0.38%	15,891 $5.53 Million
Q2 2023 Jul 27, 2023	SELL	$314.42 - $351.91 $224,181 - $250,911	-713 Reduced 4.28%	15,951 $5.61 Million
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $859,036 - $979,962	3,033 Added 22.25%	16,664 $5.25 Million
Q4 2022 Jan 24, 2023	BUY	$285.76 - $321.48 $2.92 Million - $3.28 Million	10,203 Added 297.64%	13,631 $0
Q3 2022 Oct 17, 2022	SELL	$273.83 - $305.53 $83,518 - $93,186	-305 Reduced 8.17%	3,428 $993,000
Q2 2022 Aug 03, 2022	BUY	$234.96 - $292.55 $877,105 - $1.09 Million	3,733 New	3,733 $1.05 Million

Others Institutions Holding VRTX

# of Institutions

1,811

Shares Held

239M

Call Options Held

1.52M

Put Options Held

1.01M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $99.5B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.

Account

Fulcrum Capital LLC Vertex Pharmaceuticals Inc Transaction History